ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 82 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -82.9% | 16,650 | -52.8% | 0.00% | -100.0% |
| Q3 2020 | $117,000 | -17.0% | 35,293 | -16.2% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | -11.3% | 42,093 | +1.2% | 0.00% | 0.0% |
| Q1 2020 | $159,000 | -40.0% | 41,593 | -5.1% | 0.00% | -50.0% |
| Q4 2019 | $265,000 | -20.4% | 43,843 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $333,000 | -61.6% | 43,868 | -31.4% | 0.00% | -60.0% |
| Q2 2019 | $867,000 | +67.4% | 63,993 | -33.0% | 0.01% | +66.7% |
| Q1 2019 | $518,000 | +106.4% | 95,493 | +13.0% | 0.00% | +50.0% |
| Q4 2018 | $251,000 | -66.4% | 84,493 | -7.9% | 0.00% | -60.0% |
| Q3 2018 | $748,000 | -7.9% | 91,743 | +10.0% | 0.01% | -16.7% |
| Q2 2018 | $812,000 | +12.0% | 83,393 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $725,000 | -30.7% | 83,393 | 0.0% | 0.01% | -33.3% |
| Q4 2017 | $1,046,000 | – | 83,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 1,510,872 | $800,762 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 122,892 | $65,133 | 0.01% |
| Bernardo Wealth Planning LLC | 38,578 | $20,446 | 0.01% |
| Key FInancial Inc | 7,500 | $5,490 | 0.00% |
| Penserra Capital Management LLC | 215,722 | $114 | 0.00% |
| King Wealth Management Group | 16,000 | $8 | 0.00% |
| Newbridge Financial Services Group, Inc. | 6,075 | $3,220 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,900 | $61,427 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $26,341 | 0.00% |
| Founders Capital Management | 2,000 | $1 | 0.00% |